Abnormal microbiological findings in specimens from respiratory organs and thorax
ICD-10 R84.5 is a billable code used to indicate a diagnosis of abnormal microbiological findings in specimens from respiratory organs and thorax.
R84.5 is used to classify abnormal microbiological findings in specimens obtained from the respiratory organs and thorax, which may include sputum, bronchoalveolar lavage, pleural fluid, or lung biopsy samples. These findings can indicate the presence of pathogens such as bacteria, viruses, fungi, or atypical cells that may not be classified elsewhere. Symptoms associated with these findings can include cough, dyspnea, chest pain, fever, and hemoptysis. The abnormal results may suggest infections like pneumonia, tuberculosis, or fungal infections, as well as non-infectious conditions such as malignancies or autoimmune disorders. Accurate identification and documentation of these findings are crucial for appropriate treatment and management, as well as for coding purposes.
Detailed clinical history, laboratory results, and treatment plans must be documented. Specifics about the type of specimen and the findings should be included.
Patients presenting with chronic cough, fever, or unexplained respiratory symptoms requiring microbiological evaluation.
Ensure that all relevant clinical information is captured to support the diagnosis and the necessity of the tests performed.
Acute care documentation must include the patient's presenting symptoms, initial assessment, and any immediate interventions taken based on lab findings.
Patients with acute respiratory distress or suspected pneumonia requiring rapid microbiological assessment.
Timeliness of documentation is critical in emergency settings; ensure that findings are documented promptly to support coding.
Used when a culture is performed to identify pathogens in respiratory specimens.
Document the type of specimen and the clinical indication for the culture.
Internal medicine and infectious disease specialists often order these tests.
R84.5 includes specimens such as sputum, bronchoalveolar lavage, pleural fluid, and lung biopsy samples that show abnormal microbiological findings.